Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 35,516 shares at $10.04 ($363K) on 2020-03-02, disclosed to the SEC on 2020-03-04.
Open-market sale of $363k VNDA by SVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.04 | 12,223 | $123K | 33.8% |
| 2 | $10.04 | 12,223 | $123K | 33.8% |
| 3 | $10.66 | 5,535 | $59K | 16.2% |
| 4 | $10.66 | 5,535 | $59K | 16.2% |
| Total | $10.23 avg | 35,516 | $363K | 100% |
| Filing → |
| VNDA | SELL | 2023-03-06 | $209K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |